Travere Therapeutics
TVTX
TVTX
116 hedge funds and large institutions have $691M invested in Travere Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-17
Holders Change %
-12.78%
% of All Funds
3.05%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
19
Increased
51
Reduced
31
Closed
36
Calls
$61.1M
Puts
$40.2M
Net Calls
+$20.9M
Net Calls Change
-$22.9M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.5M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$7.14M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$7.12M |
| 4 |
BC
Broadfin Capital
New York
|
+$6.75M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$6.5M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$10.8M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$6.06M |
| 3 |
QF
QVT Financial
New York
|
-$6.01M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.88M |
| 5 |
Morgan Stanley
New York
|
-$4.75M |
